Form 8-K - Current report:
SEC Accession No. 0001104659-23-066363
Filing Date
2023-05-31
Accepted
2023-05-31 09:25:02
Documents
15
Period of Report
2023-05-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317400d1_8k.htm   iXBRL 8-K 28952
2 EXHIBIT 3.1 tm2317400d1_ex3-1.htm EX-3.1 7833
3 EXHIBIT 99.1 tm2317400d1_ex99-1.htm EX-99.1 11177
7 GRAPHIC tm2317400d1_ex99-1img001.jpg GRAPHIC 4285
  Complete submission text file 0001104659-23-066363.txt   237365

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vstm-20230530.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20230530_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20230530_pre.xml EX-101.PRE 22595
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2317400d1_8k_htm.xml XML 3710
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 23979193
SIC: 2834 Pharmaceutical Preparations